Skip to Content

54 346 (Lithium Carbonate Extended Release 450 mg)

Pill with imprint 54 346 is White, Round and has been identified as Lithium Carbonate Extended Release 450 mg. It is supplied by Roxane Laboratories, Inc..

Lithium is used in the treatment of bipolar disorder; schizoaffective disorder; mania and belongs to the drug class antimanic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 450 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 54 346

Lithium carbonate extended release 450 mg 54 346
Lithium carbonate extended release 450 mg 54 346  Front
Lithium carbonate extended release 450 mg 54 346  Back
Lithium carbonate extended release 450 mg 54 346
Lithium carbonate extended release 450 mg 54 346

Lithium Carbonate Extended Release

Imprint
54 346
Strength
450 mg
Color
White
Size
11.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antimanic agents
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Roxane Laboratories, Inc.
Inactive Ingredients
ferric oxide yellow, magnesium stearate, povidone, sodium alginate, sodium starch glycolate type A potato

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00054-0020 Roxane Laboratories, Inc.
68084-0655 Amerisource Health Services

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.